The global anti-inflammatory drugs market consists of drugs that are primarily used for treating inflammation-related diseases like arthritis, multiple sclerosis, and inflammatory bowel diseases. Some of the common anti-inflammatory drugs available are corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), biologics, interferons, and interleukin inhibitors. These drugs work by inhibiting the activity of inflammatory signaling molecules like cytokines and prostaglandins and reducing joint swelling, pain, and stiffness. They provide effective relief from inflammation and are usually prescribed as first-line treatment for several chronic inflammatory conditions. The increasing geriatric population suffering from age-related inflammatory disorders and the rising incidence of target diseases are major factors fueling the demand for anti-inflammatory drugs. The Global Anti-Inflammatory Drugs Market is estimated to be valued at US$ 118.21 Bn in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Anti-Inflammatory Drugs Market Size are 48 London, Alpine Escape, Arburton Ltd, Aspen Luxury Concierge Service LLC, AZ Luxe, Bon Vivant, Globe Infinite, Ibiza Luxury Concierge Service, Innerplace Co., and John Paul. These companies are focusing on new product launches and strategic collaborations to expand their market share. For instance, in 2021, 48 London launched an advanced anti-inflammatory skincare range using clinically-proven ingredients.

The global anti-inflammatory drugs market is witnessing high demand due to the increasing prevalence of chronic inflammatory conditions like arthritis, asthma, and inflammatory bowel disease. As per estimates, over 150 million people worldwide suffer from osteoarthritis and over 5.3 million have rheumatoid arthritis. This growing patient pool is driving significant sales of anti-inflammatory medications.

The market is also growing due to the increasing geographical outreach of key pharmaceutical manufacturers. Companies are actively expanding to emerging nations in Asia Pacific and Latin America through partnerships and acquisitions. This is helping them tap new revenue streams and further enhance their global market share.

Market drivers

One of the key drivers of the anti-inflammatory drugs market is the rising geriatric population globally. As age advances, the risk of developing inflammatory health issues like arthritis, gout, and muscle pain increases substantially. According to data, by 2050, over 22% of the world’s population will be aged 60 years and above. This demographic shift will augment the demand for anti-inflammatory medications for alleviating age-related inflammatory conditions. Another major factor is the continuous drug development and approval for improved therapies against inflammatory disorders. This encouraging pipeline is expected to introduce advanced treatment options and propel market revenues.

How Current Geopolitical Situation is Impacting ANTI-INFLAMMATORY DRUGS Market Growth and Future Strategies

The current geopolitical tensions and conflicts globally are impacting the anti-inflammatory drugs market growth. The Russia-Ukraine war has disrupted supply chains massively. Both Russia and Ukraine are major suppliers of raw materials used in the manufacturing of anti-inflammatory drugs like ibuprofen. The restrictions on trade and sanctions on Russia have led to shortages and price hikes of these raw materials in global markets. This is negatively impacting production volumes for drug makers catering to markets in North America and Europe specifically.

Get more insights on Anti-Inflammatory Drugs Market

Also read related article on Bioreactors Market